Cargando…

Values of debulking surgery for unresectable well-differentiated metastatic pancreatic neuroendocrine tumors: a comparative study

BACKGROUND AND OBJECTIVE: The value of debulking surgery for unresectable well-differentiated metastatic pancreatic neuroendocrine tumor (m-PNET) remains poorly defined. This study aimed to evaluate the outcomes of m-PNET following debulking surgery in our institute. METHODS: Patients with well-diff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Xi-Tai, Xie, Jin-Zhao, Chen, Liu-Hua, Cai, Jian-Peng, Chen, Wei, Liang, Li-Jian, Zhang, Ning, Yin, Xiao-Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995090/ https://www.ncbi.nlm.nih.gov/pubmed/36911142 http://dx.doi.org/10.1093/gastro/goad010

Ejemplares similares

Values of spleen-preserving distal pancreatectomy in well-differentiated non-functioning pancreatic neuroendocrine tumors: a comparative study
por: Huang, Xi-Tai, et al.
Publicado: (2022)

Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor
por: Ito, Tetsuhide, et al.
Publicado: (2013)

Phase II study of lanreotide autogel in Japanese patients with unresectable or metastatic well-differentiated neuroendocrine tumors
por: Ito, Tetsuhide, et al.
Publicado: (2017)

Systemic Therapy in Metastatic or Unresectable Well-Differentiated/Dedifferentiated Liposarcoma
por: McGovern, Yevette, et al.
Publicado: (2017)

Efficacy and safety of sunitinib in Japanese patients with progressive, advanced/metastatic, well-differentiated, unresectable pancreatic neuroendocrine tumors: final analyses from a Phase II study
por: Ito, Tetsuhide, et al.
Publicado: (2019)

Observational Study in a Real-World Setting of Targeted Therapy in the Systemic Treatment of Progressive Unresectable or Metastatic Well-Differentiated Pancreatic Neuroendocrine Tumors (pNETs) in France: OPALINE Study
por: Smith, Denis, et al.
Publicado: (2022)

Two well-differentiated pancreatic neuroendocrine tumor mouse models
por: Wong, Chung, et al.
Publicado: (2019)

Neoadjuvant Chemotherapy with Capecitabine and Temozolomide for Unresectable Pancreatic Neuroendocrine Tumor
por: Devata, Sumana, et al.
Publicado: (2012)

Safety and Efficacy of Sunitinib in Patients with Unresectable Pancreatic Neuroendocrine Tumors
por: Wiedmann, Marcus W., et al.
Publicado: (2012)

Effect of Endostar combined with chemotherapy in advanced well-differentiated pancreatic neuroendocrine tumors
por: Cheng, Yue-Juan, et al.
Publicado: (2018)

Analysis of recurrence after resection of well-differentiated non-functioning pancreatic neuroendocrine tumors
por: Tan, Qing-quan, et al.
Publicado: (2020)

Metastatic well differentiated serotonin-producing pancreatic neuroendocrine tumor with carcinoid heart disease: a case report
por: Kudelka, Matthew R., et al.
Publicado: (2023)

Novel EUS-guided microwave ablation of an unresectable pancreatic neuroendocrine tumor
por: Robles-Medranda, Carlos, et al.
Publicado: (2022)

Heart Failure in a Patient With Metastatic Well-Differentiated Neuroendocrine Tumor
por: Henderson, Amy, et al.
Publicado: (2023)

Adaptive Tomotherapy for locally advanced unresectable pancreatic neuroendocrine tumor: Case report and literature review
por: Tu, Kuan-Yi, et al.
Publicado: (2022)

Optimal Lymphadenectomy in Patients with Well-Differentiated Nonfunctioning Pancreatic Neuroendocrine Neoplasms
por: Shintakuya, Ryuta, et al.
Publicado: (2023)

Metastatic well-differentiated neuroendocrine carcinoma of the pancreas: case report and review of literature
por: Martin, Mersadies R, et al.
Publicado: (2009)

A practical proposal on treatment sequencing of metastatic well-differentiated neuroendocrine tumours
por: Perrier, Marine, et al.
Publicado: (2023)

Predictors of Long-Term Outcomes After Liver Transplantation for Unresectable Metastatic Neuroendocrine Tumors
por: Kuncewicz, Mikołaj, et al.
Publicado: (2023)

Role of palliative resection of the primary pancreatic neuroendocrine tumor in patients with unresectable metastatic liver disease: a systematic review and meta-analysis
por: Zhou, Bo, et al.
Publicado: (2018)

Genomic characterization of a well-differentiated grade 3 pancreatic neuroendocrine tumor
por: Williamson, Laura M., et al.
Publicado: (2019)

Primary debulking surgery for metastatic cervical adenocarcinoma: A case report
por: Davenport, Sara M., et al.
Publicado: (2015)

Targeted deep sequencing reveals the genetic heterogeneity in well-differentiated pancreatic neuroendocrine tumors with liver metastasis
por: Zhou, Wentao, et al.
Publicado: (2022)

Combination of endobronchial bronchoscopic debulking and bronchoplastic segmentectomy of an obstructive neuroendocrine tumour: probably the least invasive approach
por: Mégevand, Vladimir, et al.
Publicado: (2022)

Metastatic neuroendocrine pancreatic tumor – Case report
por: Radu, EC, et al.
Publicado: (2018)

Chronic venulectasias secondary to persistent flushing in the setting of a metastatic well-differentiated neuroendocrine tumor
por: Pope, Eleanor M., et al.
Publicado: (2022)

The differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma: the values of CT imaging features and texture analysis
por: Guo, Chuangen, et al.
Publicado: (2018)

Phase I/II study of streptozocin monotherapy in Japanese patients with unresectable or metastatic gastroenteropancreatic neuroendocrine tumors
por: Komoto, Izumi, et al.
Publicado: (2022)

Metronomic temozolomide as second line treatment for metastatic poorly differentiated pancreatic neuroendocrine carcinoma
por: De Divitiis, C., et al.
Publicado: (2016)

Updated Efficacy and Safety Outcomes for Patients with Well-Differentiated Pancreatic Neuroendocrine Tumors Treated with Sunitinib
por: Fazio, Nicola, et al.
Publicado: (2021)

Metastatic pancreatic neuroendocrine tumors feature elevated T cell infiltration
por: Greenberg, Jacques, et al.
Publicado: (2022)

Primary Well-Differentiated Neuroendocrine Tumor of the Kidney
por: Prasad, Vishnu, et al.
Publicado: (2023)

The Value of Alkaline Phosphatase-to-Albumin Ratio in Detecting Synchronous Metastases and Predicting Postoperative Relapses among Patients with Well-Differentiated Pancreatic Neuroendocrine Neoplasms
por: Zhou, Wentao, et al.
Publicado: (2020)

Association of Neutrophil, Platelet, and Lymphocyte Ratios with the Prognosis in Unresectable and Metastatic Pancreatic Cancer
por: Allen, Jessica, et al.
Publicado: (2020)

CAPTEM in Metastatic Well-Differentiated Intermediate to High Grade Neuroendocrine Tumors: A Single Centre Experience
por: Sahu, Arvind, et al.
Publicado: (2019)

Clinical and Pathological Features of Primary Renal Well-Differentiated Neuroendocrine Tumor
por: Jiang, Hua, et al.
Publicado: (2022)

Involvement of Neutrophils in Metastatic Evolution of Pancreatic Neuroendocrine Tumors
por: Debien, Véronique, et al.
Publicado: (2021)

The impact of surgery in metastatic pancreatic neuroendocrine tumors: a competing risk analysis
por: He, Chao-bin, et al.
Publicado: (2019)

Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial
por: Krug, Sebastian, et al.
Publicado: (2021)

Clinical and Molecular Risk Factors for Recurrence Following Radical Surgery of Well-Differentiated Pancreatic Neuroendocrine Tumors
por: Pulvirenti, Alessandra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ff4anibjrmelpgkq6ni8kpf3f1